Variant report
Variant | nsv1037329 |
---|---|
Chromosome Location | chr13:65583733-65673656 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs545373317 | chr13:65597849-65597850 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs2324735 | chr13:65597898-65597899 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs531119936 | chr13:65597949-65597950 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs543395748 | chr13:65597955-65597956 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs563288511 | chr13:65597983-65597984 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs528982866 | chr13:65597994-65597995 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs549129553 | chr13:65598006-65598007 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs543208737 | chr13:65598020-65598021 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs561929440 | chr13:65598043-65598044 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs565881110 | chr13:65598058-65598059 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs528331158 | chr13:65598082-65598083 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs113049751 | chr13:65598102-65598103 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs77390639 | chr13:65598141-65598142 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs571476098 | chr13:65598177-65598178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs185215631 | chr13:65598204-65598205 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs536965375 | chr13:65598227-65598228 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs547336045 | chr13:65598238-65598239 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs116308673 | chr13:65598285-65598286 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs567355419 | chr13:65598309-65598310 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs536323940 | chr13:65598327-65598328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs149554673 | chr13:65598391-65598392 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs78606626 | chr13:65598400-65598401 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs9598940 | chr13:65598427-65598428 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs189693552 | chr13:65598435-65598436 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs545542545 | chr13:65598439-65598440 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs558888632 | chr13:65598455-65598456 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs148863096 | chr13:65598459-65598460 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs182045559 | chr13:65598462-65598463 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs551768406 | chr13:65598469-65598470 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs143487645 | chr13:65598470-65598471 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs1340812 | chr13:65598491-65598492 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs9528876 | chr13:65598522-65598523 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs559361390 | chr13:65598528-65598529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs9540330 | chr13:65598529-65598530 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs551527995 | chr13:65598535-65598536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs564945113 | chr13:65598576-65598577 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs567898106 | chr13:65598627-65598628 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs535329880 | chr13:65598636-65598637 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs372848553 | chr13:65598712-65598713 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs7984878 | chr13:65598723-65598724 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs376533889 | chr13:65598743-65598744 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs188006201 | chr13:65598789-65598790 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs567316470 | chr13:65598790-65598791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs529524948 | chr13:65603805-65603806 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs555688675 | chr13:65603813-65603814 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs12877761 | chr13:65603841-65603842 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs6562404 | chr13:65603891-65603892 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs561521123 | chr13:65603909-65603910 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs527325831 | chr13:65603951-65603952 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs547090137 | chr13:65603953-65603954 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:65597800-65598200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
2 | chr13:65598000-65598800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
3 | chr13:65603800-65604200 | Active TSS | IMR90 fetal lung fibroblasts Cell Line | lung |
4 | chr13:65603800-65604200 | Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
5 | chr13:65611000-65611400 | Enhancers | Muscle Satellite Cultured Cells | -- |
6 | chr13:65611200-65611600 | Enhancers | A549 | lung |
7 | chr13:65621600-65622000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
8 | chr13:65638000-65638600 | Enhancers | A549 | lung |
9 | chr13:65638000-65639600 | Enhancers | Fetal Heart | heart |
10 | chr13:65638600-65639600 | Weak transcription | A549 | lung |
11 | chr13:65639600-65639800 | Enhancers | A549 | lung |
12 | chr13:65649600-65651200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
13 | chr13:65662800-65667400 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
14 | chr13:65663400-65664600 | Enhancers | Fetal Lung | lung |
15 | chr13:65663600-65664000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
16 | chr13:65663800-65664000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
17 | chr13:65664600-65669400 | Weak transcription | Fetal Lung | lung |
18 | chr13:65665200-65665400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
19 | chr13:65665400-65666400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
20 | chr13:65666400-65666600 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
21 | chr13:65669400-65669800 | Enhancers | Fetal Lung | lung |
22 | chr13:65669400-65670000 | Enhancers | Brain Hippocampus Middle | brain |
23 | chr13:65669600-65670000 | Enhancers | Brain Cingulate Gyrus | brain |
24 | chr13:65669800-65670200 | Flanking Active TSS | Fetal Lung | lung |